Condition Lookup

Relapsing Polychondritis

Specialty: Ear

Category: Autoimmune and Systemic Conditions with Ear Involvement

Symptoms:
recurrent inflammation of cartilage (ears, nose, trachea); ear pain; hearing loss; redness and swelling of the pinna; joint pain; respiratory symptoms

Root Cause:
Immune system targets cartilaginous tissues, leading to recurrent inflammation and degradation.

How it's Diagnosed: videos
Clinical features, imaging (CT/MRI), cartilage biopsy, and exclusion of other conditions.

Treatment:
Corticosteroids, immunosuppressive agents, and symptomatic management for respiratory and joint involvement.

Medications:
Prednisone (corticosteroid), methotrexate (immunosuppressant), and biologics like rituximab (monoclonal antibody).

Prevalence: How common the health condition is within a specific population.
Rare; estimated 3.5 cases per million population annually.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Unknown; may be associated with other autoimmune diseases.

Prognosis: The expected outcome or course of the condition over time.
Highly variable; relapsing course with potential for life-threatening complications if untreated.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Airway collapse, aortic aneurysm, hearing loss, and cosmetic deformities.

Autoimmune Inner Ear Disease (AIED)

Specialty: Ear

Category: Autoimmune and Systemic Conditions with Ear Involvement

Symptoms:
progressive hearing loss; tinnitus; dizziness; balance problems; ear fullness

Root Cause:
Immune system attacks the inner ear, leading to inflammation and damage to auditory and vestibular structures.

How it's Diagnosed: videos
Clinical evaluation, audiometry, imaging (MRI to rule out other causes), and response to corticosteroid treatment.

Treatment:
Corticosteroids to reduce inflammation, immunosuppressive therapies, hearing aids, or cochlear implants in severe cases.

Medications:
Corticosteroids like prednisone (anti-inflammatory) and methotrexate (immunosuppressive) are commonly prescribed.

Prevalence: How common the health condition is within a specific population.
Rare; estimated to affect 1 in 100,000 individuals annually.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Personal or family history of autoimmune diseases, middle-aged adults.

Prognosis: The expected outcome or course of the condition over time.
Variable; hearing loss may stabilize with treatment but can progress without intervention.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Permanent hearing loss, balance disorders, and reduced quality of life.

Cogan’s Syndrome

Specialty: Ear

Category: Autoimmune and Systemic Conditions with Ear Involvement

Symptoms:
interstitial keratitis; hearing loss; vertigo; tinnitus; systemic vasculitis symptoms such as fever and fatigue

Root Cause:
Autoimmune reaction targeting the eyes and inner ear, often associated with systemic vasculitis.

How it's Diagnosed: videos
Clinical history, ophthalmologic examination, audiometry, MRI to exclude other conditions, and inflammatory markers.

Treatment:
Systemic corticosteroids, immunosuppressive drugs, and supportive care for hearing and vision.

Medications:
Prednisone (corticosteroid) and cyclophosphamide (immunosuppressive) are commonly used; TNF-alpha inhibitors may be considered.

Prevalence: How common the health condition is within a specific population.
Extremely rare; fewer than 300 reported cases worldwide.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Unknown; may be linked to genetic predisposition or autoimmune conditions.

Prognosis: The expected outcome or course of the condition over time.
With prompt treatment, systemic and ocular symptoms can improve, but hearing loss may persist or progress.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Permanent hearing loss, blindness, systemic vasculitis, organ damage.

Wegener’s Granulomatosis (Granulomatosis with Polyangiitis)

Specialty: Ear

Category: Autoimmune and Systemic Conditions with Ear Involvement

Symptoms:
chronic sinusitis; nasal crusting; hearing loss; tinnitus; ear pain; systemic symptoms like fever, weight loss, and fatigue

Root Cause:
Autoimmune-mediated inflammation of blood vessels (vasculitis) affecting multiple organs, including the ears.

How it's Diagnosed: videos
Blood tests for ANCA (antineutrophil cytoplasmic antibodies), biopsy of affected tissue, and imaging studies.

Treatment:
Immunosuppressive therapy, corticosteroids, and supportive care for organ-specific damage.

Medications:
Rituximab (biologic), cyclophosphamide (immunosuppressant), and prednisone (corticosteroid).

Prevalence: How common the health condition is within a specific population.
Rare; approximately 3 cases per 100,000 population annually.

Risk Factors: Factors or behaviors that increase the likelihood of developing the condition.
Unknown; potential genetic and environmental triggers.

Prognosis: The expected outcome or course of the condition over time.
Improved with early diagnosis and treatment; potential for remission, though relapses are common.

Complications: Additional problems or conditions that may arise as a result of the original condition.
Hearing loss, renal failure, pulmonary hemorrhage, and life-threatening vasculitis.